Literature DB >> 16514067

N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways.

M Abedin1, J Lim, T B Tang, D Park, L L Demer, Y Tintut.   

Abstract

Fish oil supplementation is associated with lower risk of coronary artery disease in humans, and it has been shown to reduce ectopic calcification in an animal model. However, whether N-3 fatty acids, active ingredients of fish oil, have direct effects on calcification of vascular cells is not clear. In this report, we investigated the effects of eicosapentaenoic acid and docosahexaenoic acid (DHA) on osteoblastic differentiation and mineralization of calcifying vascular cells (CVCs), a subpopulation of bovine aortic medial cells that undergo osteoblastic differentiation and form calcified matrix in vitro. Results showed that N-3 fatty acids inhibited alkaline phosphatase (ALP) activity and mineralization of vascular cells, suggesting that they directly affect osteoblastic differentiation in vascular cells. By Western blot analysis, DHA activated p38-mitogen-activated protein kinase (MAPK) but not extracellular-regulated kinase (ERK) or Akt. An inhibitor of p38-MAPK partially reversed the inhibitory effects of DHA on osteoblastic differentiation and mineralization. Transient transfection experiments showed that DHA also activated peroxisome proliferator-activated receptor-gamma (PPAR-gamma). Both p38-MAPK activator and PPAR-gamma agonists reproduced the inhibitory effects of DHA on CVC mineralization. Pretreatment with DHA also inhibited interleukin-6-induced ALP activity and mineralization. Together, these results suggest that N-3 fatty acids directly inhibit vascular calcification, and that the inhibitory effects are mediated by the p38-MAPK and PPAR-gamma pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16514067     DOI: 10.1161/01.RES.0000216009.68958.e6

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  37 in total

1.  Cholesterol in vascular and valvular calcification.

Authors:  L L Demer
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

2.  The ω-3 epoxide of eicosapentaenoic acid inhibits endothelial cell proliferation by p38 MAP kinase activation and cyclin D1/CDK4 down-regulation.

Authors:  Pei H Cui; Nenad Petrovic; Michael Murray
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 3.  The role of noninvasive cardiovascular testing, applied clinical nutrition and nutritional supplements in the prevention and treatment of coronary heart disease.

Authors:  Mark Houston
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-01-10

4.  Heat shock protein 70 enhances vascular bone morphogenetic protein-4 signaling by binding matrix Gla protein.

Authors:  Yucheng Yao; Andrew D Watson; Sheng Ji; Kristina I Boström
Journal:  Circ Res       Date:  2009-08-06       Impact factor: 17.367

Review 5.  Vascular calcification: pathobiology of a multifaceted disease.

Authors:  Linda L Demer; Yin Tintut
Journal:  Circulation       Date:  2008-06-03       Impact factor: 29.690

Review 6.  The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcification.

Authors:  Linda Demer; Yin Tintut
Journal:  Circ Res       Date:  2011-06-10       Impact factor: 17.367

7.  Saturated phosphatidic acids mediate saturated fatty acid-induced vascular calcification and lipotoxicity.

Authors:  Masashi Masuda; Shinobu Miyazaki-Anzai; Audrey L Keenan; Kayo Okamura; Jessica Kendrick; Michel Chonchol; Stefan Offermanns; James M Ntambi; Makoto Kuro-O; Makoto Miyazaki
Journal:  J Clin Invest       Date:  2015-10-26       Impact factor: 14.808

Review 8.  Vascular calcification: pathophysiology and risk factors.

Authors:  Neal X Chen; Sharon M Moe
Journal:  Curr Hypertens Rep       Date:  2012-06       Impact factor: 5.369

9.  Farnesoid X receptor activation prevents the development of vascular calcification in ApoE-/- mice with chronic kidney disease.

Authors:  Shinobu Miyazaki-Anzai; Moshe Levi; Adelheid Kratzer; Tabitha C Ting; Linda B Lewis; Makoto Miyazaki
Journal:  Circ Res       Date:  2010-04-29       Impact factor: 17.367

10.  Evidence for active regulation of pro-osteogenic signaling in advanced aortic valve disease.

Authors:  Jordan D Miller; Robert M Weiss; Kristine M Serrano; Lauren E Castaneda; Robert M Brooks; Kathy Zimmerman; Donald D Heistad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-09-23       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.